App to prevent postpartum depression tested on 3,000 women

NCT ID NCT07613008

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a mobile app called e-Perinatal designed to prevent depression and anxiety during and after pregnancy. The app offers personalized tips, mental health tracking, and a support button. Researchers will enroll 3,000 pregnant women across primary care centers in Spain to see if using the app reduces the number of new cases of depression and anxiety compared to standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

mobile health (mHealth) program (e-Perinatal app)

What this could lead to

If it works, this could provide a scalable, low-cost way to prevent mental health disorders in new mothers using a smartphone app.

What could go wrong

This is a large trial but still early-stage for implementation. The app's effectiveness may vary by user engagement, and it relies on self-reporting and digital access, which may not reach all women equally.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERINATAL DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder Depression perinatal asphyxia prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••